Establishing realistic expectations around weightloss magnitude, time to benefit, and chronic nature of therapy, particularly regarding potential weight regain after discontinuation
That is a rare clinical scenario and it is not the use case being marketed to the public
Patients with pre-existing gastroparesis, significant gastrointestinal disease, or previous gastric surgery require particularly careful monitoring and may benefit from gastroenterology consultation before initiating GLP-1 agonist therapy
Unlike single target mono agonists, this triple receptor agonist system triggers concurrent intracellular transduction pathways via cyclic adenosine monophosphate cAMP accumulation and beta arrestin recruitment assays
Functional MRI data show that Sema alters activation in brain regions involved in reward and motivation, including the insula, putamen, and orbitofrontal cortex, which are associated with food cue reactivity and cravings